Our client is an agricultural-biotechnology company that uses gene editing in developing novel plant varieties. They have developed a Gene editing/Gene Silencing platform which combines the benefits of Gene Editing and RNAi technologies while overcoming their distinct challenges. Over the last year, they have been exploring the potential benefit of their platform in the human therapeutic context and found it to be a unique approach with specific technological and regulatory advantages They are now interested in establishing a dedicated new company to use their platform in advancing attractive therapeutic products and thus require an experienced CEO to lead this new venture.
The role holder must possess the strategic thinking, vision and communication skills to create a successful business. Key early deliverables will be defining which target therapeutic applications on which to focus, creating the key value-creation milestones the new company will need to accomplish and raising additional investment based on the business case.
Candidates required to have a good knowledge of Gene Editing and RNAi technologies, a prior track record of full P&L such as that gained working as a Country GM or CEO and the strategic thinking, vision and communication skills to create a successful business. Fundraising experience highly preferable.